• 1
    Del Tacca M, Pasqualetti G, Di Paolo A, Virdis A, Massimetti G, Gori G, Versari D, Taddei S, Blandizzi C. Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers. Br J Clin Pharmacol 2009; 68: 3442.
  • 2
    Directive 2001/83/EC of the European Parliament and of the Council of 6 April 2001 on the Community Code Relating to Medicinal Products for Human Use. OJEC 2004; L311: 67128.
  • 3
    U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Rockville, MD: U.S.Food and Drug Administration, 2009. Available at